stone disease

Persistent decline in renal function seen after first stone case“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.
Hydroxycitrate may have utility in treating stonesA new laboratory study suggests that a widely available nutritional supplement has potential to become a new treatment for the wide majority of kidney stones. Clinical research is still pending, however, and there are important caveats about the findings.
Pediatric urolithiasis: Update and practical pointers
Pediatric urolithiasis: Update and practical pointersThis article provides an update on the risk factors for stone disease and its presentation in children, and offers practical tips on its evaluation, treatment, and prevention.
Basic Science Research: Trimodal therapy shows promise in oligometastatic PCaOther basic science research pearls include preliminary evidence from a porcine model suggesting botulinum toxin type A facilitates ureteral stone passage and the identification of two different microdeletions in the NELL1 gene on chromosome 11 in men with Peyronie's disease.
Stone Disease: New AUA guide discusses SWL vs. URSOther key stone disease/endourology topics from the 2016 AUA annual meeting included the use of aspirin in percutaneous nephrolithotomy patients as well as the continuing debate over the benefit of medical expulsive therapy.
Urinary proteome may hold key to stone preventionA recent study provides the first comprehensive catalog of urinary calcium oxalate monohydrate binding proteins.
Data reveal big changes in PCNL use in U.S.Trends in percutaneous nephrolithotomy may reflect other stone treatment trends, study authors say.
Dusting vs. basketing: Which method is better?
Dusting vs. basketing: Which method is better?Researchers from the Endourology Disease Group for Excellence research consortium compared the techniques in 152 patients at several stone centers.
AUA 2016: Experts offer guidance on the meetingTo guide you through the 2016 AUA annual meeting and help maximize your time, Urology Times’ editorial board has reviewed the program to identify the key trends and noteworthy research at this year’s meeting.
Shock wave lithotripsy: Down, but not outOnce considered a primary option for kidney stone treatment, shock wave lithotripsy appears to be losing traction. Many urologists say its outcomes aren’t as reliable as those from ureteroscopy. But others say it remains an option that works well with proper patient selection and technique and offers what ureteroscopy doesn’t: a noninvasive option.